GenSight Biologics
BiotechnologyParis, Ile-de-France, FrancePost-IPO Equity$284.1M total fundingwww.gensight-biologics.com
Latest funding:$2.0M · Post-IPO Equity (March 10, 2026)
Angel investors who backed GenSight Biologics
32 investors in our database backed GenSight Biologics.
Anne Osdoit
Partner
Bali Muralidhar
Managing Partner, Chief Investment Officer
Jacques Theurillat
Partner
Kurt von Emster
Board Member
andrew sinclair
Managing Director
Vin Miles
Executive Director
Genghis Lloyd-Harris
Senior Advisor
John Heard
General Counsel
Tim Haines
Chairman and Managing Partner
Brian Atwood
Founder, CEO
Charles Warden
Managing Director
Ross Jaffe
Managing Director
Joel Drewry
Principal
Robin Praeger
Managing Director/Advisor
Bill Link
investor
Don Milder
Managing Partner
Beckie Robertson
Founder and General Partner
Barbara Lubash
Managing Director (Emeritus) and Co-Founder
Rachel Lane PhD
Chief Business Officer
guido magni
Partner ,Versant Ventures
Clare Ozawa
Managing Director
Brad Bolzon
Chairman, Managing Director
Alexander Mayweg
Managing Director
Paul Grayson
Partner
Fang Ni
Principal
Chris Jackson
MBA Candidate
Staffan Lindstrand
Partner
Johan Christenson
Partner
Anki Forsberg
Partner
Nikki Matthews
Senior Vice President
Keith Underwood
Senior Vice President
Jason Dodd
Board Member
Find the right investors for your startup
Search thousands of angel investors and VCs by industry, stage, check size, and location — and see who backed companies like GenSight Biologics.
Search investors